000 | 01686 a2200505 4500 | ||
---|---|---|---|
005 | 20250513135315.0 | ||
264 | 0 | _c19980409 | |
008 | 199804s 0 0 eng d | ||
022 | _a0021-9738 | ||
024 | 7 |
_a10.1172/JCI1065 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLaine, H | |
245 | 0 | 0 |
_aInsulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity. _h[electronic resource] |
260 |
_bThe Journal of clinical investigation _cMar 1998 |
||
300 |
_a1156-62 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBlood Flow Velocity |
650 | 0 | 4 |
_aBlood Glucose _xanalysis |
650 | 0 | 4 |
_aBradykinin _xpharmacology |
650 | 0 | 4 | _aFluorodeoxyglucose F18 |
650 | 0 | 4 |
_aGlucose _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperinsulinism _xmetabolism |
650 | 0 | 4 |
_aInsulin _xblood |
650 | 0 | 4 | _aInsulin Resistance |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMuscle, Skeletal _xdrug effects |
650 | 0 | 4 |
_aObesity _xmetabolism |
650 | 0 | 4 |
_aThigh _xblood supply |
650 | 0 | 4 | _aTomography, Emission-Computed |
650 | 0 | 4 |
_aVasodilation _xdrug effects |
650 | 0 | 4 |
_aWater _xpharmacology |
700 | 1 | _aYki-Jarvinen, H | |
700 | 1 | _aKirvela, O | |
700 | 1 | _aTolvanen, T | |
700 | 1 | _aRaitakari, M | |
700 | 1 | _aSolin, O | |
700 | 1 | _aHaaparanta, M | |
700 | 1 | _aKnuuti, J | |
700 | 1 | _aNuutila, P | |
773 | 0 |
_tThe Journal of clinical investigation _gvol. 101 _gno. 5 _gp. 1156-62 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1172/JCI1065 _zAvailable from publisher's website |
999 |
_c9455160 _d9455160 |